🏥 Health Jun 3, 2026

Columbia Research Helps Propel Daraxonrasib, a Potential New Standard of Care for Pancreatic Cancer

Columbia University Medical Center
Columbia medical news
View Channel →
Source ↗ 👁 36 💬 0
Daraxonrasib nearly doubled survival in patients with advanced pancreatic cancer in a landmark phase 3 trial.

Comments (0)

Sign in to join the discussion

More Like This

📰
More REM sleep linked to lower risk of 83 diseases
Health & Medicine News -- ScienceDaily · 3d ago
📰
GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
Health & Medicine News -- ScienceDaily · 3d ago
White House plan to increase control of NIH grants appears ‘dead’
STAT · 4d ago
Menopausal Hormone Therapy Thrombotic Risk Varies by Dose, Route of Administration
MedPageToday.com - medical news for physicians · 4d ago
STAT+: Nominee to lead FDA aims to speed up medical research, combat China’s rise
STAT · 4d ago
📰
Gifts from Friends provides thoughtful way to celebrate
Vanderbilt Health News · 4d ago